Table of Content

Table of Contents

Global Recurrent Glioblastoma Multiforme Treatment Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 AU-105 -Product Introduction and Major Manufacturers
1.1.2 Axitinib -Product Introduction and Major Manufacturers
1.1.3 AXL-1717 -Product Introduction and Major Manufacturers
1.1.4 AZD-7451 -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.1.1 China Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.1.2 China Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.2.1 EU Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.2.2 EU Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.3.1 USA Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.3.2 USA Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.4.1 Japan Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.4.2 Japan Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.5.1 India Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.5.2 India Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.6.1 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.7.1 South America Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.7.2 South America Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Recurrent Glioblastoma Multiforme Treatment Status and Prospect (2015-2026)
2.8.1 Recurrent Glioblastoma Multiforme Treatment Market Size and Growth Rate (2015-2026)
2.8.2 Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Recurrent Glioblastoma Multiforme Treatment Market Assessment by Segment
3.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity and Growth Rate
3.2 Global Recurrent Glioblastoma Multiforme Treatment Sales by Type
3.3 Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue by Type
3.4 Global Recurrent Glioblastoma Multiforme Treatment Consumption by Application
4 Global Recurrent Glioblastoma Multiforme Treatment Market Assessment by Regions
4.1 Global Recurrent Glioblastoma Multiforme Treatment Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Recurrent Glioblastoma Multiforme Treatment Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Recurrent Glioblastoma Multiforme Treatment Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Recurrent Glioblastoma Multiforme Treatment Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share of Manufacturers (2019-2020)
6.3 Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue Market Share of Manufacturers (2019-2020)

7 Recurrent Glioblastoma Multiforme Treatment Competitive Analysis
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Profiles
7.1.2 Boehringer Ingelheim GmbH Product Introduction
7.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Boston Biomedical, Inc.
7.2.1 Boston Biomedical, Inc. Company Profiles
7.2.2 Boston Biomedical, Inc. Product Introduction
7.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Profiles
7.3.2 Bristol-Myers Squibb Company Product Introduction
7.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Cantex Pharmaceuticals, Inc.
7.4.1 Cantex Pharmaceuticals, Inc. Company Profiles
7.4.2 Cantex Pharmaceuticals, Inc. Product Introduction
7.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Cavion LLC
7.5.1 Cavion LLC Company Profiles
7.5.2 Cavion LLC Product Introduction
7.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Celldex Therapeutics, Inc.
7.6.1 Celldex Therapeutics, Inc. Company Profiles
7.6.2 Celldex Therapeutics, Inc. Product Introduction
7.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Company Profiles
7.7.2 Coherus BioSciences, Inc. Product Introduction
7.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Cortice Biosciences, Inc.
7.8.1 Cortice Biosciences, Inc. Company Profiles
7.8.2 Cortice Biosciences, Inc. Product Introduction
7.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Eisai
7.9.1 Eisai Company Profiles
7.9.2 Eisai Product Introduction
7.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Profiles
7.10.2 Eli Lilly and Company Product Introduction
7.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 EnGeneIC Ltd
7.12 ERC Belgium SA
7.13 GenSpera, Inc.
7.14 Genzyme Corporation
7.15 GW Pharmaceuticals Plc
7.16 ImmunoCellular Therapeutics, Ltd.
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Recurrent Glioblastoma Multiforme Treatment Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Unit) by Type (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share (%) by Type (2019 -2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Value (Million USD) by Type (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Value Market Share (%) by Type (2019-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Unit) by Application (2015-2026)
Figure China Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table China Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table India Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Units) and Growth Rate (2015-2026)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (Unit) by Type (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Recurrent Glioblastoma Multiforme Treatment Consumption (Unit) by Application (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Recurrent Glioblastoma Multiforme Treatment Production (K Unite) by Regions (2015-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Production Share by Regions (2019-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales (K Unite) by Regions (2015-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Share by Regions (2019-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Recurrent Glioblastoma Multiforme Treatment
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Recurrent Glioblastoma Multiforme Treatment
Figure Cost Structure of Recurrent Glioblastoma Multiforme Treatment in 2020
Table Global Recurrent Glioblastoma Multiforme Treatment Capacity Share of Manufacturers (2019-2020)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity Share of Manufacturers (2019-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share of Manufacturers (2019-2020)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Market Share of Manufacturers (2019-2020)
Table Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Recurrent Glioblastoma Multiforme Treatment Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ??Boehringer Ingelheim GmbH Profiles
Table ??Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ??Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ??Boehringer Ingelheim GmbH SWOT Analysis
Table ????Boston Biomedical, Inc. Profiles
Table ????Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Boston Biomedical, Inc. SWOT Analysis
Table ????Bristol-Myers Squibb Company Profiles
Table ????Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bristol-Myers Squibb Company SWOT Analysis
Table ????Cantex Pharmaceuticals, Inc. Profiles
Table ????Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cantex Pharmaceuticals, Inc. SWOT Analysis
Table ????Cavion LLC Profiles
Table ????Cavion LLC Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Cavion LLC Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cavion LLC SWOT Analysis
Table ????Celldex Therapeutics, Inc. Profiles
Table ????Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Celldex Therapeutics, Inc. SWOT Analysis
Table ????Coherus BioSciences, Inc. Profiles
Table ????Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Coherus BioSciences, Inc. SWOT Analysis
Table ????Cortice Biosciences, Inc. Profiles
Table ????Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cortice Biosciences, Inc. SWOT Analysis
Table ????Eisai Profiles
Table ????Eisai Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Eisai Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eisai SWOT Analysis
Table ????Eli Lilly and Company Profiles
Table ????Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eli Lilly and Company SWOT Analysis
Table ????EnGeneIC Ltd Profiles
Table ????EnGeneIC Ltd Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????EnGeneIC Ltd Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????EnGeneIC Ltd SWOT Analysis
Table ????ERC Belgium SA Profiles
Table ????ERC Belgium SA Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????ERC Belgium SA Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????ERC Belgium SA SWOT Analysis
Table ????GenSpera, Inc. Profiles
Table ????GenSpera, Inc. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????GenSpera, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????GenSpera, Inc. SWOT Analysis
Table ????Genzyme Corporation Profiles
Table ????Genzyme Corporation Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????Genzyme Corporation Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Genzyme Corporation SWOT Analysis
Table ????GW Pharmaceuticals Plc Profiles
Table ????GW Pharmaceuticals Plc Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????GW Pharmaceuticals Plc Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????GW Pharmaceuticals Plc SWOT Analysis
Table ????ImmunoCellular Therapeutics, Ltd. Profiles
Table ????ImmunoCellular Therapeutics, Ltd. Recurrent Glioblastoma Multiforme Treatment Product Introduction
Table ????ImmunoCellular Therapeutics, Ltd. Recurrent Glioblastoma Multiforme Treatment Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????ImmunoCellular Therapeutics, Ltd. SWOT Analysis